Surgery Partners (SGRY) Invested Capital (2013 - 2026)

Surgery Partners has disclosed Invested Capital across 14 years of filings, most recently posting $3.1 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $3.1 billion, down 32.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (down 32.63% YoY), and the FY2025 annual result was $4.5 billion, down 1.98% from the prior year.
• Invested Capital came in at $3.1 billion for Q1 2026 at Surgery Partners, down from $4.5 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $4.6 billion in Q4 2024 to a low of $2.6 billion in Q1 2022.
• The 5-year median for Invested Capital is $4.0 billion (2025), against an average of $3.8 billion.
• Across the five-year window, Invested Capital soared 83.01% in 2022 and slumped 32.63% in 2026, its largest moves.
• Surgery Partners' Invested Capital stood at $4.3 billion in 2022, then rose by 3.08% to $4.4 billion in 2023, then climbed by 3.69% to $4.6 billion in 2024, then slipped by 1.98% to $4.5 billion in 2025, then sank by 32.11% to $3.1 billion in 2026.
• The last three Invested Capital figures came in at $3.1 billion (Q1 2026), $4.5 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.